Fortis Healthcare
- Advice
- Hold
Fortis Healthcare Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Fortis Healthcare
Start SIPFortis Healthcare Investment Rating
-
Master Rating:
-
Fortis Healthcare (Nse) has an operating revenue of Rs. 5,939.80 Cr. on a trailing 12-month basis. An annual revenue growth of 41% is outstanding, Pre-tax margin of 17% is great, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 14% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 57 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 67 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of B is close to being the best. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|
| Oper Rev Qtr Cr | 266 | 247 | 210 |
| Operating Expenses Qtr Cr | 228 | 215 | 191 |
| Operating Profit Qtr Cr | 38 | 32 | 19 |
| Depreciation Qtr Cr | 29 | 28 | 28 |
| Interest Qtr Cr | 28 | 28 | 33 |
| Tax Qtr Cr | 4 | 3 | -2 |
| Net Profit Qtr Cr | 82 | -8 | -24 |
Fortis Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 281.28
- 50 Day
- 282.28
- 100 Day
- 280.45
- 200 Day
- 274.51
- 20 Day
- 282.59
- 50 Day
- 283.87
- 100 Day
- 281.9
- 200 Day
- 270.5
Fortis Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 281.2 |
| Second Resistance | 284.2 |
| Third Resistance | 287.4 |
| RSI | 43.21 |
| MFI | 38.4 |
| MACD Single Line | -0.85 |
| MACD | -1.49 |
| Support | |
|---|---|
| First Resistance | 275 |
| Second Resistance | 271.8 |
| Third Resistance | 268.8 |
Fortis Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 643,456 | 39,656,193 | 61.63 |
| Week | 693,618 | 48,941,700 | 70.56 |
| 1 Month | 668,730 | 47,613,579 | 71.2 |
| 6 Month | 1,803,133 | 84,278,459 | 46.74 |
Fortis Healthcare Result Highlights
Fortis Healthcare Synopsis
NSE-Medical-Hospitals
Fortis Healthcare is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 862.61 Cr. and Equity Capital is Rs. 754.96 Cr. for the Year ended 31/03/2022. Fortis Healthcare Ltd. is a Public Limited Listed company incorporated on 28/02/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L85110PB1996PLC045933 and registration number is 045933.| Market Cap | 20,935 |
| Sales | 951 |
| Shares in Float | 52.09 |
| No of funds | 278 |
| Yield |
| Book Value | 2.36 |
| U/D Vol ratio | 1.1 |
| LTDebt / Equity | 7 |
| Alpha | 0.04 |
| Beta | 0.77 |
Fortis Healthcare
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 31.17% | 31.17% | 31.17% | |
| Mutual Funds | 17.5% | 16.89% | 16.25% | |
| Insurance Companies | 1.64% | 1.85% | ||
| Foreign Portfolio Investors | 31.01% | 30.59% | 29.66% | |
| Financial Institutions/ Banks | 1.19% | 1.19% | 1.19% | |
| Individual Investors | 12.39% | 12.92% | 13.58% | |
| Others | 5.1% | 5.39% | 8.15% |
Fortis Healthcare Management
| Name | Designation |
|---|---|
| Mr. Ravi Rajagopal | Chairman & Ind.Director |
| Mr. Shirish Moreshwar Apte | Vice Chairman & Non Exe.Dire |
| Dr. Ashutosh Raghuvanshi | Managing Director & CEO |
| Ms. Suvalaxmi Chakraborty | Independent Director |
| Mr. Indrajit Banerjee | Independent Director |
| Ms. Shailaja Chandra | Independent Director |
| Mr. Dilip Kadambi | Non Executive Director |
| Mr. Heng Joo Joe Sim | Non Executive Director |
| Dr. Kelvin Loh Chi-Keon | Non Executive Director |
| Dr. Farid Bin Mohamed Sani | Non Executive Director |
| Mr. Joerg Ayrle | Non Executive Director |
| Mr. Takeshi Saito | Non Executive Director |
Fortis Healthcare Forecast
Price Estimates
Fortis Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-02-10 | Quarterly Results | |
| 2022-11-11 | Quarterly Results | |
| 2022-08-05 | Quarterly Results | |
| 2022-05-25 | Audited Results | |
| 2022-02-11 | Quarterly Results |
Fortis Healthcare FAQs
What is Share Price of Fortis Healthcare ?
Fortis Healthcare share price is ₹277 As on 05 February, 2023 | 16:46
What is the Market Cap of Fortis Healthcare ?
The Market Cap of Fortis Healthcare is ₹20935 Cr As on 05 February, 2023 | 16:46
What is the P/E ratio of Fortis Healthcare ?
The P/E ratio of Fortis Healthcare is 40.9 As on 05 February, 2023 | 16:46
What is the PB ratio of Fortis Healthcare ?
The PB ratio of Fortis Healthcare is 3 As on 05 February, 2023 | 16:46